6505--Phenytoin SA Capsules (VA-25-00022318)

The Department of Veterans Affairs National Acquisition Center is soliciting proposals for Phenytoin Sodium Extended 100MG Sustained Action Capsules in two package sizes: 100-count and 1,000-count bottles. The solicitation (36E79725R0016) seeks a single aggregate award with a base year and four one-year option periods, serving multiple federal agencies including VA, DoD, Indian Health Service, Bureau of Prisons, Federal Health Care Center, and State Veterans Homes through Pharmaceutical Prime Vendor (PPV) programs. Offerors must provide a unique 11-digit NDC number and maintain the same manufacturer throughout the contract period, with potential for generic versions while allowing branded Dilantin prescriptions when clinically necessary. Proposals are due February 27, 2025, at 2:30 PM Central Time, with distributors required to submit a Letter of Commitment from the manufacturer. Pricing must incorporate a 0.5% Cost Recovery Fee and be limited to two decimal places, and the contract includes a 60-day maximum implementation period for establishing PPV distribution agreements.

The solicitation is not set aside for any specific business category and is open to pharmaceutical manufacturers and distributors in the NAICS 325412 category for Pharmaceutical Preparation Manufacturing. The estimated annual procurement includes 8,470 bottles of the 100-count size and 8,183 bottles of the 1,000-count size, indicating a substantial ongoing requirement for this medication. The contract will be executed through the VA National Acquisition Center in Hines, Illinois, with distribution managed through the respective PPV programs. While specific award value is not explicitly stated, the volume of capsules suggests a significant contract opportunity for qualified suppliers. The procurement strategy allows for flexibility in manufacturing and distribution, with a focus on ensuring consistent supply of this critical medication across multiple federal healthcare systems.